Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Outlook Therapeutics (OTLK)
NASDAQ:OTLK
RESEARCH TOOLSreports
Holding OTLK?
Track your performance easily
Outlook Therapeutics (OTLK) Ownership Overview
37.80% Insiders
3.77% Mutual Funds
19.26% Other Institutional Investors
6.12% ETFs
33.06% Public Companies and
Individual Investors
The ownership structure of Outlook Therapeutics (OTLK) stock is a mix of institutional, retail, and individual investors. Approximately 29.15% of the company’s stock is owned by Institutional Investors, 37.80% is owned by Insiders, and 33.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | Lawrence Kenyon Cfo,director | xxxxxxxxxxxxx | $28400 |
| Mar 29, 2024 | Yezan Munther Haddadin Director | xxxxxxxxxxxxx | $22233 |
| Mar 11, 2024 | Jeff Evanson Cco | xxxxxxxxxxxxx | $26243 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,808,074 | Insider | 24.55% | 30,376,227 | |
| 1,705,438 | Insider | 7.21% | 8,919,441 | |
| 810,498 | Institution | 3.43% | 4,238,905 | |
| 808,459 | Insider | 3.42% | 4,228,241 | |
| 593,502 | Institution | 2.51% | 3,104,015 | |
| 487,998 | Institution | 2.06% | 2,552,230 | |
| 473,117 | Insider | 2.00% | 2,474,402 | |
| 152,245 | Institution | 0.64% | 796,241 | |
| 151,508 | Institution | 0.64% | 792,387 | |
| 86,120 | Institution | 0.36% | 450,408 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 487,998 | Institution | 2.06% | 2,552,230 | |
| 152,245 | Institution | 0.64% | 796,241 | |
| 86,120 | Institution | 0.36% | 450,408 | |
| 39,919 | Institution | 0.17% | 208,776 | |
| 33,905 | Institution | 0.14% | 177,323 | |
| 33,160 | Institution | 0.14% | 173,427 | |
| 16,005 | Institution | 0.07% | 83,706 | |
| 10,671 | Institution | 0.05% | 55,809 | |
| 9,309 | Institution | 0.04% | 48,686 | |
| 5,578 | Institution | 0.02% | 29,173 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 442,511 | Institution | 1.87% | 2,363,009 | |
| 393,545 | Institution | 1.66% | 2,058,240 | |
| 281,280 | Institution | 1.19% | 1,502,035 | |
| 104,526 | Institution | 0.44% | 546,671 | |
| 68,651 | Institution | 0.29% | 366,596 | |
| 57,640 | Institution | 0.24% | 301,457 | |
| 34,543 | Institution | 0.15% | 180,660 | |
| 8,682 | Institution | 0.04% | 46,362 | |
| 8,321 | Institution | 0.04% | 45,849 | |
| 4,347 | Institution | 0.02% | 31,360 |
FAQ
Who Owns Outlook Therapeutics (OTLK)?
According to the latest TipRanks data, approximately 19.26% of the company's stock is held by institutional investors, 37.80% is held by insiders, and 33.06% is held by retail investors.
What percentage of Outlook Therapeutics (OTLK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 19.26% of Outlook Therapeutics (OTLK) stock is held by institutional investors.
What percentage of Outlook Therapeutics (OTLK) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.06% of Outlook Therapeutics (OTLK) stock is held by retail investors.
Who owns the most shares of Outlook Therapeutics (OTLK)?
Ghiath M. Sukhtian owns the most shares of Outlook Therapeutics (OTLK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.